Dynamics of accessibility of medicines for type 2 diabetes monotherapy in Ukraine
Journal Title: Фармацевтичний журнал - Year 2017, Vol 1, Issue 1
Abstract
Diabetes mellitus is recognized as noninfectious epidemic in the world. Antidiabetic medications for the patients are taking continually and they are expensive. So, the actual question is the evaluation of the economic availability of antidiabetic treatment. Compared with other similar researches the economic availability of monotherapy of type 2 diabetes mellitus in Ukraine has not been investigated. It was researched in this study. The purpose of the research was scientific generalization of the results of study of the economic availability of monotherapy of type 2 diabetes mellitus in Ukraine from 2013 to 2016. The material of the study were: ATC/DDD-indexes of Centre WHO methodology of statistical studies of drugs, cost of DDDs was calculated according to weighed average cost in November 2013 and November 2016, according to weekly «Pharmacy» information. Methods: frequency analysis, ATC/DDD-methodology, the calculation of socio-economic coefficients of accessibility: liquidity ratio (Cliq), solvency adequacy ratio (Ca.s.), availability ratio (D). Based on the results of our previous studies to analyze the dynamics of socio-economic accessibility have been selected schemes of monotherapy with metformin, gliclazide and glimepiride, as the most commonly used in clinical practice. It has been found that the minimum price for DDD of metformin increased by 101%, for glimepiride – by 65%, for gliclazide – by 41% from 2013 to 2016. In the study of liquidity ratio Cliq, it has been found that there was an increase of price fluctuations from 48 to 295%. In the study of the solvency adequacy ratio Ca.s., it has been found that the accessibility has decreased from 98 to 197%, respectively. In studying of availability ratio D it has been found that the growth rate of salary was lower rates therapy price increases by 67% for metformin, by 44% for glimepiride, by 5% for gliclazide. In the study of economic availability it has been found an increase in prices in 1.4 times for metformin, in 1.25 times – for glimepiride, in 4.3 times – for gliclazide. Accessibility of monotherapy of type 2 diabetes mellitus has been decreased by 98–197%. The rate of wage growth was less than the growth rate of prices for the medications under investigation by 5–67%. The obtained results of a study of the socio-economic accessibility of medicines for type 2 diabetes monotherapy for the population of Ukraine Cliq, Ca.s., D against the background of reducing the rate of salary growth show a decrease in the dynamics of such availability in the period 2013–2016 years.
Authors and Affiliations
T. A. Germanyuk, T. I. Ivko, V. P. Bobruk
Keywords
Related Articles
- EP ID EP553990
- DOI 10.32352/0367-3057.1.17.05
- Views 57
- Downloads 0
Clinical and economic analysis of pharmacotherapy for patients with ulcer in the terms of prepaid funds
Digestive diseases are the third leading cause of appeals in all age groups for medical help after the pathologies of the circulatory and respiratory system. In Ukraine, the number of patients needing specialized gastroe...
External reference pricing in the pharmaceuticals price regulation
Regulation of drug prices is an important part of regulation of the pharmaceutical market, and requires a rationalization and systematic approach. Study of the application of an external reference pricing (ERP) should be...
Classification, general description and procedure of taking of food products to category the «special food products» in Ukraine from position of pharmaceutical law
To date assortment policy pharmacies in Ukraine has grown significantly due to food products such as: dietary supplements, functional foods, foods for special dietary use. In this connection, the purpose of the work was...
Optimization of quality assurance system for pharmaceutical care based on the principles of risk management
In today's widespread use of medicines to ensure their efficacy and safety, physical and economic access to medicines, quality control, rational choice, the issues of pharmaceutical care are the topical issue of pharmace...
Research of influence of pharmaceutical factors on the process of creation of pills with the operating substance of a 1 class of BSС on the example of bisoprolol fumarate
Among the diseases of population of Ukraine and world the first place is occupied by the diseases of the cardiovascular system. The evidential base of efficiency of application of b-blockers at the different forms of isc...